Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

Christophe Cellier, Gerd Bouma, Tom van Gils, Sherine Khater, Georgia Malamut, Laura Crespo, Pekka Collin, Peter H.R. Green, Sheila E. Crowe, Wayne Tsuji, Eric Butz, Nadine Cerf-Bensussan, Elizabeth Macintyre, Jane R. Parnes, Francisco Leon, Olivier Hermine, Chris J. Mulder, Bana Jabri, Joseph Murray, Anthony DiMarinoCiaran P. Kelly, Valerie Byrnes, David Sanders, Knut EA Lundin, Michael Schumann, Hetty Bontkes, Bertrand Meresse, Garbiñe Roy Ariño, Govind Bhagat, Keijo Viiri, Samuli Rounioja, Jack Bui, Raquel Perez Maseda, Carlota García-Hoz, Amelie Trinquand, George Vlad, Marios Hadjivassiliou, Michel Azizi, Anne Blanchard, Beth Llewellyn, Ashleigh Palmer, Ralph Raymond

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study'. Together they form a unique fingerprint.

Medicine & Life Sciences